• Eric Lim on treatments for pleural mesothelioma
    May 10 2024

    Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma.

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Show more Show less
    6 mins
  • Anne Chang on the burden of chronic respiratory diseases in Indigenous people
    Apr 24 2024

    Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people.

    Read the full article:
    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00008-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Show more Show less
    10 mins
  • Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC
    Mar 12 2024

    Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell lung cancer.

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Show more Show less
    10 mins
  • Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID
    Jan 16 2024

    Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated to affect up to 20% of those infected with SARS-CoV-2.

    Read the full article:
    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00414-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Show more Show less
    8 mins
  • Sarah Gorst and Tim Nicholson on long COVID outcomes
    Nov 2 2023

    Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVID and how it will be used to inform future research and clinical care.

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Show more Show less
    16 mins
  • Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19
    Oct 4 2023

    Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19.

    Read the full article:
    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00262-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Show more Show less
    12 mins
  • Keith Chappell on a bivalent recombinant vaccine for COVID-19
    Sep 13 2023

    Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials.

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Show more Show less
    8 mins
  • James Chalmers on bronchiectasis across Europe
    Apr 26 2023

    Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry.

    Read the full article:
    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00093-0/fulltext?dgcid=buzzsprout_tlv_episode-notes_general_general

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Show more Show less
    12 mins